Skip to main content
. Author manuscript; available in PMC: 2017 Apr 24.
Published in final edited form as: AIDS. 2016 Apr 24;30(7):1005–1014. doi: 10.1097/QAD.0000000000001038

Figure 2. HIV-specific activity of IgG antibodies in CVL and plasma.

Figure 2

IgG binding antibodies were measured in CVL and plasma from the 7 CAPRISA 002 women who developed broadly cross neutralizing antibodies. Dots represent CVL and plasma samples from 1 year (red), 2 years (green) and 3 years (blue) post HIV infection. Reactivity to 8 antigens was evaluated via a customized binding antibody multiplex assay (BAMA). The median fluorescence intensity (MFI) values were normalized to total IgG concentration (specific activity). Samples that had MF1<100 were considered non-responders therefore the points are not reflected on the plots. Responders had a specific activity >0.01 for all antigens.